The medical device industry garnered significant investor attention amid the COVID-19 pandemic. And with worldwide COVID-19 cases again on the rise, the industry may gain renewed traction with investors. According to WHO, more than 11 million new COVID-19 infections were registered last week, representing an 8% increase.
Furthermore, an increased number of patients with chronic diseases globally, along with an aging population that continues to grow, should lead to a continuing increase in demand for medical devices. Investors’ interest in this space is evidenced by the iShares U.S. Medical Devices ETF’s (IHI) 10.5% returns over the past year.
